Paracoccidioidomycosis (PCM) is a systemic mycosis caused by the thermodimorphic fungus Paracoccidioides brasiliensis. Leukotrienes and lipoxins are lipid mediators produced after 5-lipoxygenase (5-LO) activation that exhibit pro-and anti-inflammatory roles, respectively. Here, we have investigated the contribution of 5-LO enzymatic activity in PCM using an experimental model of P. brasiliensis infection. B6.129 wild-type (B6.129) and 5-LO-deficient (5-LO ؊/؊ ) mice were intravenously inoculated with a virulent strain of P. brasiliensis (Pb18), and the survival rate of the infected mice was investigated on different days after yeast infection. 5-LO ؊/؊ mice exhibited an increased survival rate associated with a decreased number of CFU. The resistance of 5-LO ؊/؊ during PCM was associated with augmented nitric oxide (NO) production and the formation of compact granulomas. In addition, the absence of 5-LO was associated with a diminished number of CD4 ؉ CD25 ؉ regulatory T cells, higher levels of gamma interferon and interleukin-12, and increased T-bet (a T-box transcription factor that directs Th1 lineage commitment) mRNA levels in the lungs. Taken together, our results show for the first time that 5-LO enzymatic activity increases susceptibility to P. brasiliensis, suggesting that this pathway may be a potential target for therapeutic intervention during PCM.
P aracoccidioidomycosis (PCM), an important chronic systemic mycosis endemic in rural areas of Latin America, is caused by the thermodimorphic fungus Paracoccidioides brasiliensis. PCM affects approximately 10 million people and results in a mortality rate of 1.4 per 1 million inhabitants (1, 2) . Moreover, PCM is considered a critical social and economic problem because it occurs in individuals in the most productive stage of life and culminates in frequent anatomic and functional sequelae (3) . T helper 1 (Th1)-type cytokines such as interleukin-12 (IL-12) and gamma interferon (IFN-␥) are implicated in resistance during P. brasiliensis infection, while the predominant production of Th2-type cytokines contributes to the disseminated form of the disease (4) . The infection also leads to the differentiation of T CD4 ϩ
CD25
ϩ FOXP3 ϩ cells, which migrate to the lesion site to inhibit T cell proliferation and favor a latent form of the disease (5, 6) .
Lipoxins and leukotrienes are lipid mediators formed by the 5-lipoxygenase (5-LO)-catalyzed oxidation of arachidonic acid (7, 8) . The interaction of the 5-LO enzyme with a 5-LO-activating protein (FLAP) allows the conversion of arachidonic acid into the unstable leukotriene A 4 (LTA 4 ). The 5-LO biosynthetic pathways can be triggered after activation by a variety of stimuli, including fungal products (9) . The two bioactive classes of leukotrienes, LTB 4 and cysteinyl leukotrienes (CysLT), participate in protection during infectious diseases by promoting cellular activation, vasodilatation, and increased vascular permeability (10) . Conversely, lipoxins are involved in the downmodulation of the inflammatory response, including the production of IL-12 and IFN-␥ (11, 12) .
Because little is known about the mechanisms underlying the immune response during PCM, we sought here to investigate the role of the 5-LO activity in a murine model of systemic P. brasiliensis infection using B6.129 wild-type and 5-LO-deficient mice (5-LO Ϫ/Ϫ ). 5-LO Ϫ/Ϫ mice exhibited diminished fungal growth and increased survival rate compared to B6.129 mice. The protection observed in 5-LO Ϫ/Ϫ mice was associated with reduced expression of GITR and FOXP3 by CD4 ϩ CD25 ϩ cells and increased production of IFN-␥ in the lungs. The blockage of the lipoxin receptor FPR2 in B6.129 mice led to a decreased number of fungal cells in the lungs, suggesting that FPR2 ligands, as lipoxins, could contribute to the inhibition of the host response in PCM. In conclusion, our data show for the first time that 5-LO enzymatic activity increases susceptibility during experimental P. brasiliensis infection in mice.
B6.129 and 5-LO Ϫ/Ϫ mice (30 mice in each group) was verified daily for a period of 110 days.
In vivo treatment with lipoxin receptor antagonists. The peptides BOC-2 (Boc-Phe-Leu-Phe-Leu-Phe; Phoenix Pharmaceuticals, Burlingame, CA) and WRW4 (Tocris Bioscience, Ellisville, MO) were used in vivo as nonselective and selective lipoxin receptor antagonists, respectively, as previously reported (16, 17) . B6.129 mice were intraperitoneally treated with BOC-2 (10 g/kg/day, 0.1 ml) every 48 h from days Ϫ1 to 29 postinfection (p.i.). Similarly infected control B6.129 mice were treated with vehicle (Vhc) alone (0.5% methanol). WRW4 treatment (1 mg/kg/ day, 0.1 ml, given intraperitoneally) started on day Ϫ1 and was reinforced every 72 h until day 8 p.i. Control mice for WRW4 treatment received Vhc alone (dimethyl sulfoxide [DMSO] at 0.1%).
Assay for CFU. The number of viable yeast cells in organs (lungs, liver, and spleen) from Pb18-infected mice was determined at 7, 15, 30, 60, and 90 days p.i. by counting CFU as previously described (6) . Plates were incubated at 35 to 37°C for 7 days, and the amount of CFU per g of tissue was calculated.
Organ morphology and morphometry of pulmonary granulomas. Whole lungs were excised, fixed with 10% formalin for 24 h, and embedded in paraffin. Tissue sections (5 m) were stained with hematoxylin and eosin (H&E) for lesion analysis or impregnated with silver to demonstrate reticulum fibers using standard protocols. Images were captured with a digital camera (Olympus) adapted to a common optical microscope. Morphometric analyses were performed using panoramic images of lungs (magnification, ϫ10): the pulmonary inflammatory area was manually drawn and measured using ImageJ software (National Institutes of Health; http://rsbweb.nih.gov/ij/). The lesion index was then calculated (the sum of the inflammatory area ϫ the lung area Ϫ1 ). Immunohistochemistry. Frozen lung sections (5 m) were obtained from B6.129 and 5-LO Ϫ/Ϫ Pb18-infected mice, and an immunohistochemical reaction was performed as previously described (6) . Slides were incubated with anti-mouse IgG as control or rabbit IgG anti-mouse 5-LO, NOS-2 or CD4 (Santa Cruz Biotechnology, Santa Cruz, CA) diluted 100 times in PBS (5-LO and CD4) or PBS-0.01% saponin (NOS-2). We measured immunostained areas using ImageJ software. Briefly, after defining the range of brown color considered to be positive, the images were converted to 256 shades (8-bit) of gray. The grayscale image was converted to binary (black and white) to define the cutoff point. The threshold was adjusted, and the brown areas became black portions in the binary image. The percentage of stained area was automatically analyzed.
Measurement of cytokines and lipid mediators in lung supernatant. Lungs were removed from mice on days 7, 15, 30, 60, and 90 p.i., weighed, and homogenized in 1 ml of protease inhibitor cocktail buffer (Complete; Roche, Mannheim, Germany) using a tissue homogenizer. After centrifugation (5,000 ϫ g for 10 min), the supernatants were harvested and dispensed (0.05 ml) into a 96-well plate containing capture monoclonal antibodies. The levels of IFN-␥, IL-12p40, IL-12p70, IL-6, and IL-10 were measured by standard sandwich enzyme-linked immunosorbent assay (ELISA; BD Pharmingen, San Jose, CA). The optical densities were measured at 450 nm using a microplate ELISA reader (EMAX; Molecular Devices). To assay the amount of lipid mediators, the samples were centrifuged at 5,000 ϫ g for 10 min, and the supernatant was purified with Sep-Pak C18 cartridges according to the manufacturer's instructions (Waters Corp., Milford, MA). Eicosanoid levels were measured using commercial kits obtained from Neogen Corp. (LXA 4 ) and Cayman Chemical Co (LTB 4 and CysLT).
Nitrite quantification in lung tissue. The lungs were removed, weighed, homogenized, and centrifuged as described above. The assay was performed in a microplate by mixing 0.05 ml of lung homogenate with 0.05 ml of nitrate reductase solution to convert nitrate into nitrite. Next, 0.1 ml of Griess reagent was mixed (18) , and the optical densities were measured at 540 nm. The nitrite concentration was determined with reference to a standard curve of 1 to 200 M NaNO 2 .
Isolation of leukocytes from lung tissue and flow cytometry analysis. Lungs were removed and placed in RPMI 1640 with Liberase CI enzymes (0.5 mg/ml; Boehringer Ingelheim Chemicals, Inc., Petersburg, VA). After 1 h at 37°C, the samples were crushed through a 50-m-poresize filter (Falcon products) and centrifuged (250 ϫ g, 10 min). Next, leukocytes were collected, and the expression of CD11b, CD11c, CD3, CD8, CD4, CD25, CTLA-4, CD103, GITR, and FOXP3 was assessed by flow cytometry as previously reported (6) . The data acquisition was performed on a fluorescence-activated cell sorting Canto II (BD Immunocytometry Systems) flow cytometer and analyzed using FlowJo software (Tree Star, Inc., Ashland, OR).
cDNA synthesis and quantitative real-time PCR (qRT-PCR). Total RNA was isolated from the lungs using an Illustra RNAspin minikit containing RNase-free DNase to avoid any genomic DNA contamination (GE Healthcare) as described by the manufacturer. The following primer pairs were used: 5-LO, 5=-CCA AAT GCC ACA AGG AT (forward) and 5=-CGC TTT TGA GTA GTT CAG AAC (reverse); Arginase-1, 5=-GTT CCC AGA TGT ACC AGG ATT C (forward) and 5=-CGA TGT CTT TGG CAG ATA TGC (reverse); NOS-2, 5=-CGA AAC GCT TCA CTT CCA A (forward) and 5=-TGA GCC TAT ATT GCT GTG GCT (reverse); T-bet, 5=-CCC CTG TCC AGT CAG TAA CTT (forward) and 5=-CTT CTC TGT TTG GCT GGC T (reverse); and Glyceraldehyde Phosphate Dehydrogenase (GAPDH), 5=-TGC AGT GGC AAA GTG GAG AT (forward) and 5=-CGT GAG TGG AGT CAT ACT GGA A (reverse). First-strand cDNA was synthesized from 2 g of total RNA using a SuperScript III reverse transcriptase kit (Invitrogen) and oligo(dT) primers according to the manufacturer's instructions. Amplification assays were carried out in duplicate on a 7000 Sequence Detection Systems device (Applied Biosystems, Foster City, CA) in 15-l volumes containing 5 l of cDNA, 0.5 l (1 to 2 g) of each primer (reverse and forward), 6.5 l of Platinum SYBR green qPCR master mix (Life Technologies, Carlsbad, CA), and 2.5 l of Milli-Q H 2 O. After initial denaturation at 50°C for 2 min and 95°C for 2 min, amplifications were carried out for 40 cycles at 95°C for 15 s and 58°C for 30 s, and finally 72°C for 30 s. The expression of each mRNA was normalized to a housekeeping gene (GAPDH) by the threshold cycle (⌬⌬C T ) method.
Nitrite production in AM culture. Bronchoalveolar lavage fluids were obtained from 5-LO Ϫ/Ϫ and B6.129 uninfected mice as previously described (19) . After centrifugation (10 min, 350 ϫ g, 4°C), the pellets were placed in RPMI 1640 (Invitrogen Life Technologies) supplemented with 10% heat-inactivated fetal bovine serum (FBS), 100 U of penicillin/ml, 100 g of streptomycin/ml, 2 mM L-glutamine, 10 mM HEPES, 0.1 mM nonessential amino acids, and 1 mM sodium pyruvate (all from SigmaAldrich). Cell count and viability were determined by trypan blue exclusion, and cells were plated (5 ϫ 10 5 cells/well in a 96-well plate) and isolated by adherence after 4 h at 37°C in 5% CO 2 . After two washing steps with PBS, alveolar macrophages (AM) were cultivated for 18 h with fresh complete RPMI 1640 medium with 10% FBS. Then, the AM were cultured with or without P. brasiliensis yeasts cells at a 1:50 ratio of yeast to AM at 37°C in 5% CO 2 in the presence of medium, LXA 4 (100 g/ml), or BOC-2 (50 g/ml). After 48 h, supernatants were collected, and the production of nitric oxide was measured as described above.
Statistical analysis. Data are expressed as means Ϯ the standard errors of the mean (SEM). Statistical analysis was performed using analysis of variance to compare multiple groups, followed by the parametric TukeyKramer test for two-group comparison. The Gehan-Breslow-Wilcoxon method was used to compare survival curves. All analyses were performed with Prism software (version 5.0; GraphPad, San Diego, CA). A P value of Ͻ0.05 was considered statistically significant. (Fig. 1A) . To confirm these data, we investigated the effect of P. brasiliensis in the induction of 5-LO by immunohistochemistry in the lung from B6.129 mice at day 15 p.i. The immunostained area was determined by morphometric analysis, and, as shown in Fig. 1B , 27% of the total lung area was occupied by 5-LO ϩ cells in B6.129 mice, whereas Ͻ1% was found in 5-LO Ϫ/Ϫ lung (P Ͻ 0.05). We also observed that LTB 4 , CysLT, and LXA 4 levels were increased in the lungs of B6.129 mice but not in 5-LO Ϫ/Ϫ mice ( Fig. 1, C-E ). These results demonstrate that 5-LO enzymatic activity is induced by P. brasiliensis in the lungs of infected mice.
RESULTS

5-LO enzymatic activity is upregulated after
5-LO absence leads to an increased survival rate and better control of fungal growth. To directly assess whether 5-LO pathways are involved in susceptibility to PCM, B6.129 and 5-LO Ϫ/Ϫ mice were i.v. infected with 10 6 yeast cells, and the number of CFU was evaluated. At days 7 and 15 p.i., both B6.129 and 5-LO Ϫ/Ϫ mice exhibited a similar number of CFU in the lung, liver, and spleen ( Fig. 2A) . Interestingly, at days 30, 60, and 90 p.i., the number of CFU was significantly decreased in 5-LO Ϫ/Ϫ mice compared to the B6.129 group (Fig. 2A) . These data indicate that the absence of 5-LO products might contribute to the inhibition of P. brasiliensis growing in pulmonary and also in extrapulmonary tissues. To determine the effect of 5-LO activation during PCM, the survival of B6.129 and 5-LO Ϫ/Ϫ infected mice was investigated for 110 days. As shown in Fig. 2B , mortality in both groups appeared around day 40 p.i. In addition, whereas a mortality rate of 50% was observed in B6.129 mice at day 50 p.i., this percentage was only achieved 80 days after fungal challenge in 5-LO Ϫ/Ϫ mice. We also observed that 32.1% of 5-LO Ϫ/Ϫ mice survived after 110 days of infection. Together, our data indicate that effective 5-LO enzymatic activity mediates susceptibility in our experimental model of P. brasiliensis infection.
5-LO
؊/؊ mice exhibit compact granulomas in the lungs. To address whether the protection observed in 5-LO Ϫ/Ϫ mice is associated with the formation of compact granulomas and reduced pulmonary injury, histological lung sections from B6.129 and 5-LO Ϫ/Ϫ mice were analyzed at days 7, 15, 30, 60, and 90 p.i. No differences were observed in the lungs from both groups until day 15 p.i. (data not shown). After days 30 and 60 p.i., 5-LO Ϫ/Ϫ mice exhibited foci of well-organized granulomatous lesions surrounded by a great number of lymphocytes. In contrast, B6.129 mice showed diffused granulomas at the same time points of infection (Fig. 3A) . Moreover, the absence of 5-LO was associated with a normal pattern of reticulin fibers at day 30 p.i., while B6.129 mice showed an irregular distribution of these structures in the lung tissue (Fig. 3B) . To determine the extent of the inflammatory lesions, lung sections stained with H&E were analyzed by morphometric analysis. As shown in Fig. 3C , the pulmonary injury was minor in B6.129 and 5-LO Ϫ/Ϫ mice in the early periods of infection (7 and 15 days) but significantly increased in the B6.129 group 30 days after infection. However, decreased injury (P Ͻ 0.05) was observed in 5-LO Ϫ/Ϫ mice at days 30 to 90 p.i. Taken together, these results indicate that 5-LO-products have a critical role in the exacerbation of pulmonary injury caused by P. brasiliensis.
5-LO-dependent products modulate the influx of inflammatory cells to the lungs from Pb18-infected mice.
The migration and activation of inflammatory cells in the granulomas during PCM has been associated with a more efficient control of fungal growth and dissemination (20) . Therefore, we next evaluated the role of 5-LO-products in cellular recruitment. Flow cytometry analysis of cells recovered from whole lung samples showed similar numbers of Gr-1 ϩ cells in both B6.129 and 5-LO Ϫ/Ϫ mice (Fig. 4A) (Fig. 4A) . To investigate whether T cell recruitment was affected in 5-LO Ϫ/Ϫ mice, whole lung cells were analyzed at days 15 and 30 p.i., which are time points at which we have observed an increased frequency of these cells during experimental PCM (6, 21) . Although the number of CD8 ϩ T cells was similar in both groups, the amount of CD4 0.05) (Fig. 4B ). Immunohistochemical analysis in pulmonary tissue showed that 1% of the total lung area was immunostained by anti-CD4 antibody in B6.129 mice at day 30 after fungal challenge compared to 12.3% (P Ͻ 0.05) in 5-LO Ϫ/Ϫ tissue (Fig. 4C ). In addition, B6.129 mice exhibited an increased number (P Ͻ 0.05) of CD4 ϩ CD25 ϩ T cells at day 15 p.i. (Fig. 4B) , indicating that 5-LO might positively modulate the recruitment of regulatory cells in this model. Because the molecule CD25 is commonly expressed by conventional CD4 ϩ T cells (22), we analyzed other markers that are expressed in regulatory T (Treg) cells. As shown in Fig. 4D , significant levels of CD103, CTLA-4, GITR, and FOXP3 expression were observed in CD4 ϩ CD25 ϩ cells from B6.129 mice at day 15 p.i. Moreover, at day 30, the number of CD4 ϩ CD25 ϩ FOXP3 ϩ cells was significantly increased in B6.129 mice compared to the 5-LO Ϫ/Ϫ group (Fig. 4D) . Collectively, these results indicate that 5-LO products alter the composition of inflammatory cells in the infection foci.
Increased NOS-2 expression in 5-LO ؊/؊ mice during experimental PCM. Nitric oxide (NO) produced by inflammatory cells plays a well-documented role in fungal clearance (23) . Therefore, we hypothesized that the control of fungal growth observed in
5-LO
Ϫ/Ϫ mice might be dependent on NO production. We evaluated transcript levels of nitric oxide synthase (NOS-2) by qRT-PCR in the lungs of B6.129 and 5-LO Ϫ/Ϫ mice at days 15 and 30 p.i. No differences were observed in NOS-2 mRNA levels in both B6.129 and 5-LO Ϫ/Ϫ groups at day 15 p.i. However, at day 30, 5-LO Ϫ/Ϫ mice exhibited significantly increased levels of NOS-2 mRNA compared to the B6.129 group (Fig. 5A) . The percentage of NOS-2 ϩ cells was increased 2.5-fold in 5-LO Ϫ/Ϫ mice compared to the B6.129 group (Fig. 5B) . Figures 5C and D represent the expression of iNOS in B6.129 and 5-LO Ϫ/Ϫ mice, respectively. We also observed that, at day 30 p.i., NO levels were increased in the serum of 5-LO Ϫ/Ϫ mice compared to controls (data not shown). Since NOS-2 and arginase use a common substrate and can competitively metabolize L-arginine to NO and citrulline or urea and L-ornithine, respectively (24), we investigated whether arginase-1 transcripts were also affected in 5-LO Ϫ/Ϫ mice during experimental P. brasiliensis infection. Transcripts for arginase-1 were significantly decreased in 5-LO Ϫ/Ϫ lungs at days 15 and 30 p.i. compared to B6.129 (Fig. 5E) . Taken together, our data show that 5-LO interferes with the NOS-2/arginase balance during experimental PCM, which might contribute to the lack of fungal clearance in B6.129 mice during this disease.
Absence of 5-LO increases the Th1 protective response during experimental PCM. Th1-type cytokines are involved in both NO production and protection against fungal infection (25) . To determine whether the resistance observed in 5-LO Ϫ/Ϫ mice is associated with Th1 cell activation, the transcript levels for T-bet, a T box transcription factor that directs Th1 lineage commitment, were evaluated in whole lungs of B6.129 and 5-LO Ϫ/Ϫ mice. As demonstrated in Fig. 6A , 5-LO Ϫ/Ϫ mice exhibited increased levels of T-bet mRNA at day 15 p.i. (7.104 Ϯ 1.042) compared to B6.129 (3.363 Ϯ 0.101, P Ͻ 0.05). However, no differences were observed between the groups at 30 days after fungal challenge. We also observed that IL-12p40 and IFN-␥ transcripts were significantly increased in 5-LO Ϫ/Ϫ mice on day 15 of infection (data not shown). To confirm these data, IL-12 and IFN-␥ levels were measured in lung homogenate from Pb18-infected mice at different time points. Our results showed that 5-LO Ϫ/Ϫ mice exhibited a significant increase in IL-12p40, IL-12p70, and IFN-␥ production (Fig. 6, B-D) . Moreover, IL-6 levels were significantly reduced in 5-LO Ϫ/Ϫ mice at day 7 p.i., but no differences were observed for other analyzed time points (Fig. 6E) . IL-10 levels were similar in both groups at all analyzed time points (Fig. 6F) . Together, these data suggest that the absence of 5-LO induces a prominent Th1 protective response in our model of P. brasiliensis experimental infection.
FPR2 blockade partially controls fungal growth during P. brasiliensis infection. The imbalanced lipoxin and leukotriene production induced during 5-LO activation has been shown to play a critical role in the extension of the inflammatory response established against Mycobacterium tuberculosis (12, 26) . To determine which 5-LO-product could be involved in susceptibility to P. brasiliensis, the levels of both LTB 4 and LXA 4 were measured in whole lung homogenates from infected B6.129 mice. As shown in Fig. 7A , the LXA 4 levels were significantly increased at days 15 and 60 p.i. compared to LTB 4 production at the same time points of infection. Because 5-LO-dependent LXA 4 was preferentially produced in our model of fungal infection, we sought to verify whether the signaling through the lipoxin A 4 receptor FPR2 is involved in susceptibility to P. brasiliensis. Initially, B6.129 mice were intraperitoneally treated with a nonselective antagonist of FPR2 receptor, Boc-Phe-Leu-Phe-Leu-Phe (BOC-2, 10 g/kg/ day), from day Ϫ1 until day 29 p.i. on every second day. On days 15 and 30 p.i., the number of CFU recovered from lungs was determined. Our results showed that BOC-2 treatment significantly decreased CFU counts compared to the untreated control group (Fig. 7B) . In addition, NO levels were evaluated in whole lung homogenates at day 15 p.i. As shown in Fig. 7C , BOC-2 treatment resulted in increased NO production (24.58 Ϯ 6.038) compared to untreated mice (33.39 Ϯ 5.949, P Ͻ 0.05), which was also similar to the levels observed in 5-LO Ϫ/Ϫ mice (38.63 Ϯ 18.81). To confirm these results, alveolar macrophages obtained from B6.129 and 5-LO Ϫ/Ϫ uninfected mice were cultured with medium alone or in the presence of P. brasiliensis at a 1:50 ratio of yeast per macrophage plus medium, LXA 4 (100 g/ml) or BOC-2 (50 g/ml). NO levels were determined after 48 h. As shown in Fig. 7D , NO production was significantly increased when both B6.129 and 5-LO Ϫ/Ϫ alveolar macrophages were cultured with P. brasiliensis yeast cells. Moreover, the addition of LXA 4 resulted in NO levels (0.348 Ϯ 0.085) similar to B6.129 nonstimulated macrophages (0.1957 Ϯ 0.023). Conversely, BOC-2 treatment significantly increased NO production (1.092 Ϯ 0.09) compared to Pb18-stimulated B6.129 macrophages (0.5265 Ϯ 0.028, P Ͻ 0.05) iai.asm.org 1261 (Fig. 7D) . Next, IFN-␥ levels were measured in whole lung homogenates from B6.129 mice that were untreated or treated with BOC-2 at day 15 p.i. Our results showed increased IFN-␥ production in BOC-2-treated mice compared to the vehicle-treated group (Fig. 7E) . Since BOC-2 can also bind to the classical FPR receptor (27) , we treated mice with WRW4, a specific FPR2 inhibitor (28) . Corroborating our previous results, we found that disruption of the FPR2 signaling led to diminished fungal recovery in the lungs (P Ͻ 0.05) in comparison with B6.129 vehicle-treated (control) mice (Fig. 7F) . Taken together, these data suggest that blockage of signaling through the lipoxin receptor FPR2 controls fungal growth during our model of P. brasiliensis infection.
DISCUSSION
Leukotrienes and lipoxins are both involved in the modulation of immune responses during infectious diseases; while leukotrienes exhibit proinflammatory effects and increase antimicrobial defenses, lipoxins mediate anti-inflammatory responses and are associated with pathogen survival (29) . In the present study, we investigated whether 5-LO-pathway products-leukotrienes and lipoxins-are involved in an experimental model of PCM induced by the i.v. inoculation of viable Pb18 yeast cells in mice. Although pulmonary PCM is usually acquired by the respiratory route, we have shown that lungs from intravenously infected mice are widely affected (21, 25, 30, 31) , reproducing the characteristics of chronic pulmonary disease in humans and offering the advantages of reproducibility and standardization of the amount of fungal cells introduced into the host (32) . During PCM, the fungus P. brasiliensis is believed to grow inside immature granulomas and to further disseminate to different organs (20) . After P. brasiliensis infection, the 5-LO Ϫ/Ϫ mice exhibited decreased CFU in the lungs, liver and spleen and an increased survival rate compared to the wild-type group (B6.129 mice). The protection observed in 5-LO Ϫ/Ϫ mice was associated with compact granuloma formation and IL-12, IFN-␥, and NOS-2 production. Thus, our results demonstrate for the first time that 5-LO-enzimatic activity contributes to the exacerbation of experimental PCM.
In addition, we found that the levels of 5-LO-pathway derived products -leukotrienes and lipoxins-were increased in B6.129-infected mice. However, the levels of LXA 4 exceeded those of LTB 4 in the lung homogenates of wild type-infected mice. Considering that the mortality rate and CFU counts in infected B6.129 mice were prominently increased compared to 5-LO Ϫ/Ϫ mice, these data indicate that 5-LO-derived products might have a critical role in the exacerbation and severity of PCM. Accordingly, one of the 5-LO-products (lipoxin) resulted in a diminished proinflammatory and Th1 response and increased susceptibility to experimental tuberculosis (12) . The protective response observed in P. brasiliensis-infected 5-LO Ϫ/Ϫ mice indicates that the absence of both leukotrienes and lipoxins is favorable to more efficient fungal control. However, we did not administer stable LXA 4 analogs to 5-LO-deficient mice to reverse the increased resistance of 5-LO Ϫ/Ϫ mice during P. brasiliensis infection, neither addressed the role of classical leukotrienes during experimental PCM. Thus, future research investigating the role of each 5-LO-derived lipid mediator in the course of P. brasiliensis infection would be enlightening.
We observed that infected 5-LO Ϫ/Ϫ mice developed compact granulomas that showed well-defined limits. In addition, these mice exhibited a decreased pulmonary lesion index characterized by diminished inflammatory infiltrates. A reduced inflammatory response was also reported in 5-LO Ϫ/Ϫ mice during infection with Trypanosoma cruzi (33) , Mycobacterium tuberculosis (12) , and Toxoplasma gondii (34) . The granulomatous lesions are reservoirs of yeast cells that permit fungal survival in the host tissue, and the formation of compact granulomas is critical for the control of P. brasiliensis dissemination (20) . We also observed an increased number of CD11b ϩ CD11c ϩ cells and significantly increased production of IL-12 and nitric oxide in 5-LO Ϫ/Ϫ mice at day 30 p.i. Given that 5-LO-dependent production of lipoxin promotes DC "paralysis," a condition where these cells lose motility and the capacity to synthesize IL-12 (11), it is possible that the lipoxin levels observed in B6.129 mice are involved with paralysis during PCM. Accordingly, dendritic cells from 5-LO Ϫ/Ϫ mice infected with T. gondii did not exhibit paralysis (11) , indicating that 5-LO activity is critical for this event to occur. Although we have not investigated the existence of paralysis in our model, the results observed in the 5-LO knockout mice infected with P. brasiliensis strongly indicate that this phenomenon might be implicated in the reduced production of IL-12 and NO, two important mediators involved in the resistance during experimental P. brasiliensis infection (25) , in infected B6.129 mice.
In addition to the increased production of NO, we also observed that 5-LO Ϫ/Ϫ mice exhibited a significant decrease in arginase-1 transcripts compared to the B6.129 group. Given that NO and arginase-1 are expressed by classical (M1) or alternatively (M2) activated macrophages, respectively (35), these results suggest that 5-LO Ϫ/Ϫ mice might exhibit the predominant differentiation of M1 macrophages. Future research should determine the role of M1 and M2 cells and the prevalence of each subtype in 5-LO-deficient mice during P. brasiliensis infection. While M1 macrophages produce inflammatory cytokines and participate in the control of extracellular pathogens, M2 macrophages produce anti-inflammatory mediators and are involved with repair processes and termination of the immune response (36) . During acute schistosomiasis, the blockage of arginase-1 was shown to inhibit M2 macrophage differentiation and resulted in the expansion of Treg cells (37) , leading to the downmodulation of inflammatory responses. In fact, activated Treg cells can inhibit effector T cell proliferation and cytokine production (38) .
We have previously observed that the severity of PCM in patients and mice is associated with the presence of FOXP3 ϩ Treg lymphocytes in the host tissue (5, 6) . These cells promote the persistence of P. brasiliensis in lesions and might contribute to further disseminated disease (5, 6 ). In our model, 5-LO Ϫ/Ϫ mice also exhibited a diminished number of Treg cells compared to B6.129 mice, indicating that the products of 5-LO activity appear to favor the expansion of regulatory T cells. Considering that IL-10 levels were similar in B6.129 and 5-LO Ϫ/Ϫ mice, it is unlikely that this cytokine is involved in the suppression of effector cells in this model as previously demonstrated (39) .
Interestingly, B6.129 mice treated with selective or nonselective antagonists of the LXA 4 receptor FPR2 (WRW4 and BOC-2, respectively) showed a significantly reduced fungal recovery in the lungs. Moreover, we observed that BOC-2 treatment restored NO and IFN-␥ production. Taken together, our data suggest that FPR2 signaling could be a negative regulator of the immune response against fungal cells, and the activation of this pathway could contribute to susceptibility during P. brasiliensis experimental infection. Future studies can now be directed toward the investigation of the role of FPR2 receptors during PCM. In summary, the findings presented here show for the first time that 5-LO enzymatic activity increases susceptibility to P. brasiliensis and suggest that interruption of 5-LO signaling may represent a potential target for therapeutic intervention during paracoccidioidomycosis.
